Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 6/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5456712 | 0.98 | BBOX1 (0.44) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL25408982 | 0.86 | TSHR (0.48) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL9973818 | 0.85 | TSHR (0.52) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL14075503 | 0.83 | TSHR (0.50) | BBOX1TSHRLMNAKMT2AALDH1A1 | |
| SCHEMBL18407855 | 0.80 | BBOX1 (0.59) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL13922325 | 0.79 | DNM1 (0.48) | BBOX1TSHRLMNAKMT2AALDH1A1 | |
| SCHEMBL9242040 | 0.79 | TSHR (0.46) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL14075508 | 0.77 | MEN1 (0.50) | BBOX1TSHRLMNAKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL6427071 | 0.77 | ALDH1A1 (0.48) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL8773947 | 0.76 | HTT (0.58) | TSHRKMT2AALDH1A1HDAC11MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| EP-3728536-A1 | CLEANING AGENT CONTAINING AMYLASE WHICH IS STABILIZED USING BETAINE | Henkel AG & Co. KGaA (DE) | 2020-10-28 | — | — | EP | disclosed |
| US-9540389-B2 | Antimicrobial potentiators | MICROBIOTIX, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| US-20160075714-A1 | Antimicrobial Potentiators | MICROBIOTIX, INC. (US) | 2016-03-17 | — | — | US | disclosed |
| WO-2013052263-A2 | ANTIFUNGAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013040526-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040528-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040527-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2010056914-A1 | BACTERIAL HELICASE INHIBITOR COMPOUNDS AND USES THEREOF | MICROBIOTIX, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| US-7534816-B2 | Amidobetaines for oral care applications | GALAXY SURFACTANTS LIMITED (IN) | 2009-05-19 | — | — | US | disclosed |
| EP-1406494-B1 | BACTERICIDAL COMPOSITION COMPRISING POLYLYSIN AND PLANT NATURAL OILS | KAO CORP (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-20070004801-A1 | Amidobetaines for oral care applications | GALAXY SURFACTANTS LIMITED (IN) | 2007-01-04 | — | — | US | disclosed |
| US-6921745-B2 | Bactericidal composition comprising polylysine and a plant essential oil | KAO CORPORATION (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040132630-A1 | Bactericide comoposition | KAO CORPORATION (JP) | 2004-07-08 | — | — | US | disclosed |
| US-6004771-A | EXTRACTED MYCOBACTERIAL SAMPLE IS SUITABLE FOR DETECTION BY CULTURE AND AMPLIFICATION | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1999-12-21 | — | — | US | disclosed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004801-A1 | Amidobetaines for oral care applications | ABHD6, FFAR1, SLC6A12 | BBOX1 517/4885TSHR 2607/4885LMNA 1324/4885 |
| US-20160075714-A1 | Antimicrobial Potentiators | NR1H2, ABCC5, NR1H3 | BBOX1 1437/4885TSHR 1251/4885LMNA 4674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.